Рыночная капитализация Изменить Дата
Acadia Pharmaceuticals USD 4.53B 199M 2026-08
Akebia Therapeutics USD 427M 297M 2025-12
Almirall EUR 2.76B 472.53M 2025-12
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Amarin USD 290M 51M 2025-12
Ardelyx USD 1.48B 63M 2026-03
Astellas Pharma JPY 4.56T 770.92B 2026-03
AstraZeneca USD 178.16B 111.83B 2026-08
Charles River Laboratories USD 7.85B 2.17B 2026-03
Coherus Biosciences USD 172M 19M 2025-12
Emergent BioSolutions USD 125M 51M 2023-12
Halozyme Therapeutics USD 7.66B 257M 2026-03
Incyte USD 26.84B 4.19B 2026-08
Karyopharm Therapeutics USD 221M 95M 2026-08
Lexicon Pharmaceuticals USD 418M 73M 2025-12
MacroGenics USD 184M 82M 2026-03
Pacira USD 1.25B 333M 2026-08
Sarepta Therapeutics USD 2.28B 30M 2026-03
Takeda JPY 8.2T 809.7B 2026-06
Ultragenyx Pharmaceutical USD 2.1B 45M 2026-08
Vanda Pharmaceuticals USD 279M 6M 2024-12